BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/19/2026 12:22:17 PM | Browse: 4 | Download: 1
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 128003
DOI 10.4251/wjgo.128003
Country China
Category Oncology
Manuscript Type Basic Study
Article Title Shaoyao Decoction Suppresses Colorectal Cancer Growth by Alleviating MDSC-Mediated Immunosuppression: A Potential Role of HIF-1α Signaling
Manuscript Source Unsolicited Manuscript
All Author List Cheng-Lei Wang, Xue Chen, Xin-Yan Wang, Ying Wu, Bing-Wei Yang, Hao-Yu Zhai, Chong Xiao, Xi Fu, Qi-Xuan Kuang, Xue-Ke Li, Jun-Dong Wang, Feng-Ming You and Wei-Dong Li
Funding Agency and Grant Number
Funding Agency Grant Number
the National Natural Science Foundation of China 82174464
the Clinical Research Project on the Integration of Traditional Chinese and Western Medicine CXZH2025005
Corresponding Author Wei-Dong Li, Chief Physician, Department of Scientific Research Management, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, No. 5 Beixiange Street, Xicheng District, Beijing 100053, China. liweidong2072@gamyy.cn
Key Words Shaoyao decoction; Colorectal cancer; Myeloid-derived suppressor cells; Hypoxia-inducible factor 1α; Mechanistic study
Core Tip Shaoyao Decoction (SYD), a classical traditional Chinese medicine formula, exerts anti-colorectal cancer (CRC) effects in the MC38 mouse model by reshaping the MDSC-mediated immunosuppressive tumor microenvironment and inhibiting tumor growth. These effects may be associated with suppression of HIF-1α signaling in myeloid-derived suppressor cells (MDSCs). This study provides novel mechanistic insights into the immunomodulatory and therapeutic potential of SYD against CRC.
Citation Wang CL, Chen X, Wang XY, Wu Y, Yang BW, Zhai HY, Xiao C, Fu X, Kuang QX, Li XK, Wang JD, You FM, Li WD. Shaoyao decoction suppresses colorectal cancer growth by alleviating myeloid-derived suppressor cell-mediated immunosuppression: A potential role of hypoxia-inducible factor 1α signaling. World J Gastrointest Oncol 2026; In press
PDF 128003-in-press.pdf
Received
2026-09-15 07:44
Peer-Review Started
2026-09-15 07:44
First Decision by Editorial Office Director
Return for Revision
2026-10-10 03:39
Revised
2026-10-20 08:16
Publication Fee Transferred
2026-11-03 15:32
Editorial Processing by Scientific Editor
2026-11-19 06:36
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-11-19 12:22
Articles in Press
2026-11-19 12:22
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com